FREE Account Opening + No Clearing Fees
December 13, 2021 - December 15, 2021

Medplus Health IPO Review & Recommendations

Ajcon Global Services Ltd, Marwadi Shares and Finance Ltd and Ventura Securities Limited have given "Apply" recommendation to Medplus Health IPO. Capital Market, Dilip Davda and have given "May Apply" recommendation to Medplus Health IPO. Axis Capital has "Not Rated" the IPO.

Medplus Health IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 3 3 0 0 1
% 42.86 42.86 0.00 0.00 14.29

Medplus Health IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Ajcon Global Services LtdExternal link Apply
Axis CapitalExternal link Not Rated
Capital MarketExternal link May Apply
Dilip Davda May Apply
Marwadi Shares and Finance LtdExternal link Apply
InvestorGain.comExternal link May Apply
Ventura Securities LimitedExternal link Apply

Medplus Health IPO Capital Market Rating

The Captial Market ( rating for Medplus Health IPO is 47. Their analysis recommends May subscribe for the IPO.

Reviewer Rating Score Rating
Capital Market 47 May subscribe

Medplus Health IPO Review by Dilip Davda (May apply)

[Dilip Davda]  After a dismal performance for FY20, the company posted super earnings and based on these earnings, it has priced its IPO very aggressively. While the sustainability of such margins going forward raises concern, pricing of the IPO too appears greedy. Cash surplus investors may consider an investment with a long-term perspective, others may ignore. Read detail review...

Post Recommendation Manage Recommendations


  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.